What radiation dose is safe in patients with non-small-cell lung cancer?

被引:0
|
作者
Nicole A Larrier
Lawrence B Marks
机构
[1] and LB Marks is Professor and Residency Program Director,NA Larrier is a member of the faculty in the Department of Radiation Oncology
[2] Duke University Medical Center,undefined
[3] Durham,undefined
[4] NC,undefined
[5] USA.,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:80 / 81
页数:1
相关论文
共 50 条
  • [21] Exploration of lung mycobiome in the patients with non-small-cell lung cancer
    Zhao, Yiming
    Yi, Junqi
    Xiang, Juanjuan
    Jia, Wei
    Chen, Anqi
    Chen, Liyu
    Zheng, Leliang
    Zhou, Wen
    Wu, Minghua
    Yu, Zheng
    Tang, Jingqun
    BMC MICROBIOLOGY, 2023, 23 (01)
  • [22] Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer
    Manon, Rafael R.
    Jaradat, Hazim
    Patel, Rakesh
    Zhang, Tiezhi
    Fenwick, John
    Tome, Wolfgang
    Fowler, Jack
    Paliwal, Bhudatt
    Soisson, Emilie
    Yuan, Zhilong
    Mehta, Minesh
    CLINICAL LUNG CANCER, 2005, 7 (02) : 107 - 113
  • [23] Radiation Dose Escalation in Accelerated Hyperfractionated Radiotherapy for Stage III Non-small-cell Lung Cancer
    Wada, Kentaro
    Kishi, Noriko
    Kanayama, Naoyuki
    Hirata, Takero
    Morimoto, Masahiro
    Konishi, Koji
    Imamura, Fumio
    Teshima, Teruki
    Ogawa, Kazuhiko
    ANTICANCER RESEARCH, 2018, 38 (10) : 5951 - 5958
  • [24] An overview of radiation therapy in the treatment of non-small-cell lung cancer
    Al Hebshi, Adnan
    Al Hadab, Abdulrahman
    ANNALS OF THORACIC MEDICINE, 2008, 3 (06) : S89 - S96
  • [25] What is the role of novel taxanes in non-small-cell lung cancer?
    Spigel, David R.
    Greco, E. Anthony
    CLINICAL LUNG CANCER, 2008, 9 : S116 - S121
  • [26] Improving Radiation Conformality in the Treatment of Non-Small-Cell Lung Cancer
    Chang, Joe Y.
    Cox, James D.
    SEMINARS IN RADIATION ONCOLOGY, 2010, 20 (03) : 171 - 177
  • [27] Current Status of Postoperative Radiation for Non-Small-Cell Lung Cancer
    Saynak, Mert
    Higginson, Daniel S.
    Morris, David E.
    Marks, Lawrence B.
    SEMINARS IN RADIATION ONCOLOGY, 2010, 20 (03) : 192 - 200
  • [28] VeriStrat validated in patients with non-small-cell lung cancer
    Butts, Charles A.
    LANCET ONCOLOGY, 2014, 15 (07): : 671 - 672
  • [29] Managing Patients With Oligometastatic Non-Small-Cell Lung Cancer
    Stephens, Sarah Jo
    Moravan, Michael J.
    Salama, Joseph K.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (01) : 23 - +
  • [30] Immunotherapy in frail non-small-cell lung cancer patients
    Gijtenbeek, Rolof G. P.
    Noordhof, Anneloes L.
    Asmara, Oke D.
    Groen, Harry J. M.
    van Geffen, Wouter H.
    LANCET, 2024, 403 (10440): : 1986 - 1986